Cefadroxil monohydrate tablet formulation

Details Cefadroxil monohydrate tablet formulation Cefadroxil monohydrate tablet formulation

1998-03-17

2000-06-27

Spear, James M.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424464, A61K 920

Patent

active

060804270

ABSTRACT:
This invention relates to uncoated direct compression tablets containing cefadroxil monohydrate as the active ingredient, which are capable of oral administration to human beings by swallowing, chewing or disintegrating in water resulting in a drinkable dispersion.

REFERENCES:
patent: 3584114 (1971-06-01), Cavalli et al.
patent: 3725556 (1973-04-01), Hanssen et al.
patent: 3873694 (1975-03-01), Kanig
patent: 4072535 (1978-02-01), Short et al.
patent: 4414204 (1983-11-01), Tarcsay et al.
patent: 4439453 (1984-03-01), Vogel
patent: 4504657 (1985-03-01), Bouzard et al.
patent: 4851228 (1989-07-01), Zentner et al.
patent: 4910023 (1990-03-01), Botzolakis et al.
patent: 4968508 (1990-11-01), Oren et al.
patent: 5047246 (1991-09-01), Gallian et al.
patent: 5213808 (1993-05-01), Bar-Shalom et al.
patent: 5256440 (1993-10-01), Appel et al.
patent: 5284662 (1994-02-01), Koparkar et al.
patent: 5366738 (1994-11-01), Rork et al.

Affiliated with

Also associated with

Rating

Cefadroxil monohydrate tablet formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cefadroxil monohydrate tablet formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cefadroxil monohydrate tablet formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1782045